Pages

Showing posts with label cancer. Show all posts
Showing posts with label cancer. Show all posts

Wednesday, August 11, 2010

Ovarian cancer Pro diagnosis


Epithelial carcinoma of the ovary or Ovarian cancer is one of the most common gynecologic diseases. It is serious and has a very high mortality rate. It is the fifth most frequent cause of cancer death in women. It is most common in women above fifty years of age. The cancer can appear in younger women too. It is seen that women having genetic predisposition are at greater risk. Clinical statistics also show less cases of this malignancy in women using contraceptive medication. Women who have had early pregnancy or have more children also seem to be at a lower risk factor.

Prognostic factors are used to predict the likely course of ovarian cancer. Stage is the only unanimously acknowledged prognostic factor for patients with ovarian cancer. In case of advanced stage patients, volume of residual disease is considered as a diagnostic factor. To begin a prognosis and establish treatment, the physician needs to know the cell type, stage, and grade of the disease. Other factors that may be important include the patient?s age, histopathologic grade, DNA ploidy, Peritoneal fluid cytology and CA125.

The International Federation of Gynecology and Obstetrics (FIGO), has created standards for the staging of gynecological cancers. Both surgical and pathological findings are taken into account, hence it is called surgicopathologic.

Most ovarian cancer symptoms are seen only in the late stages of the disease. Ovarian cancer is treated with surgery to remove the cancerous cells. This is followed by chemotherapy. It is recommended that people experiencing vaginal bleeding, uncharacteristic period cycles, or intestinal problems should see a physician right away, so that such cases can be detected at the earliest.

Unfortunately, like most of the cancers, the exact cause of ovarian cancer is not known. It is also difficult to find precise information due to contradictory studies.








Ovarian Cancer provides detailed information on Ovarian Cancer, Ovarian Cancer Symptoms, Ovarian Cancer Treatments, Ovarian Cancer Stages and more. Ovarian Cancer is affiliated with Mesotherapy Before And After [http://www.e-MesoTherapy.com].


Monday, August 9, 2010

Peritoneal cancer


There are a variety of diseases in the world today. People are suffering from uncountable diseases and getting no cures for most of the cancer. Peritoneal cancer is one form of these cancer. It is a very rare cancer which takes place in peritoneum. This is a thin sheet which lines up the walls of the abdomen. The women who suffer from ovary cancer, and get this it diagnosed with proper medications, are the ones who are attacked by peritoneal cancer after the ovary cancer. This disease is mostly found in women.

Symptoms for this cancer are very unclear at the earlier stages of peritoneal cancer. They are very difficult to figure out the symptoms for this disease. It does not show any signs in its earlier stages and when it start to develop, and reaches it upper level, then we can figure out about this dangerous disease. This is big disadvantage, that in this modern science world, it is difficult to find the symptoms of a disease. The symptoms of this disease are very much similar to the symptoms of the disease known as ovarian cancer.

Below are some of the symptoms listed for peritoneal cancer:

1: too much blood flow from vagina

2: feeling as you are stuffed, although you had a very light meal

3: continuous vomiting

4: loss of appetite

5: nausea

6: continuous and abnormal weight gain

Peritoneal cancer can be diagnosed in multiple ways. It is firstly diagnosed through X Rays or the alternative CT scans. One more method for diagnosing this disease is peritoneoscopy. This is the analysis of peritoneum, which lets you know about the disease and that you are or not a victim of this disease.

These are the major symptoms of peritoneal cancer and they can only be seen when this disease develops at the higher stage. Slowly in your body when this disease matures, the symptoms would be even clearer than before and they would be even more severe.

The treatments for peritoneal cancer are available. There are many treatments for this dangerous disease, although the success rate of these treatments are very low but still, as we say something is better than nothing. The treatments available for this disease include chemotherapy, surgery and radiation therapy. These are the mostly used treatments for this disease and patients to get cured with these treatments but the ratio of surviving patients is low.








As described in A Brief to Cancer, we can suppress the cancer cells by avoid to smoking and reducing our stress and in addition, we should do some exercises regularly and do a healthy diet to prevent another kind of cancer: Lung, Liver, Breast cancer as found in http://medicalcatalog.info.

George Collins: Sharing knowledge and opinion about interesting trends.


Primary peritoneal cancer - why every woman needs to know about this disease or else


Primary Peritoneal Cancer is a rare form of cancer (also known as peritoneal adenocarcinoma) that originates in the peritoneum, a thin sheet of fine lines inside the abdomen and covers the uterus and extends over the bladder and rectum. The peritoneum is comprised of epithelial cells. By producing a lubricating fluid, peritoneum, this helps organs move smoothly in the pelvic cavity. Primary peritoneal cancer looks and behaves like ovarian cancer but the ovaries are minimally involved. Women who develop symptoms of ovarian cancer unfortunately will probably end up with primary peritoneal cancer.

Ovarian cancer is a disease in which malignant cells are found in the ovary. There are three types of ovarian tumors: epithelial cells, germ cells and the stromal cells. The cause of ovarian cancer is unknown but there are certain risk factors that indicate an increased likelihood of a woman in developing ovarian cancer metastasis. A risk factor is anything that may increase a person's chance of developing a disease. The following have been suggested as risk factors for ovarian cancer:

Early menstruation - starting periods at an early age usually before age 12
Late menopause (after 52 years of age)
Hormone Replacement Therapy
Infertility (inability to get pregnant)
Having a first child after age 30
Personal history of breast cancer or colon cancer
Family history of ovarian cancer
Some fertility drugs
Exposure to asbestos developing into mesothelioma tumor which affects the abdominal cavity.

The diagnosis of primary peritoneal cancer consists of the following different exams:

Pelvic Exam
Ultrasound
Determination of CA-125 (a blood test to measure the level of CA-125. CA-125 is a protein also known as a Tumor marker that is often found in greater concentrations in the blood of women suffering from ovarian cancer or cancer peritoneal)
Computed Tomography (CT)
Lower GI or barium enema (a series of X-rays of the colon and rectum. The photographs were taken after the patient receives an enema with a white, chalky solution containing barium, the colon and rectum on x-ray, making tumors or other abnormal areas easier to see and detect)
Biopsy

The treatment for Primary Peritoneal Cancer depends on several factors, including: the stage of the cancer, the extent of it and the patients overall health. The treatment is a combination of the following methods; surgery, intensive chemotherapy and radiotherapy, supportive care (which is directed to the symptoms, including pain relief, weight loss and fluid in the abdomen, which can be removed during a procedure called abdominal paracentesis)

Finally we have the preventive measures suggested by physicians that include: a healthy diet (high in fruits, vegetables, grains and low in saturated fats), birth control pills, pregnancy and lactation and eventually if the person is presenting some symptoms of ovarian cancer the removal of the ovaries. Also studies have shown that certain genes are responsible for increasing the risk of ovarian and breast cancer. A routine inspection for gynaecological cancers can prevent or diagnose at an early stage the presence of tumors. Your doctor will eventually decide what treatments to carry out to help fight primary peritoneal cancer.








If you can detect the symptoms of ovarian cancer at an early stage the survival rate is much improved. Unfortunately 75% of cases are detected at an advanced stage. Make sure you are not one of those statistics. Visit our site today for more information.


Prostate cancer - overall


Device external radiation treatment

Example of an ultrasound affected by prostate cancer (ultrasound can be used to guide a biopsy). Cancer develops from the tissues of the prostate, a gland in the male reproductive system when cells will mutate to spread so uncontrollably.

These can spread (metastasize is) in migrating from the prostate to other parts of the body (especially bones and lymph nodes).

Prostate cancer occurs regardless of benign prostatic hypertrophy (or prostate adenoma). It is in the vast majority of cases adenocarcinoma.

Prostate cancer can cause pain, difficulty urinating, erectile dysfunction and other symptoms. Treatment is by surgery, radiotherapy, hormone therapy and sometimes chemotherapy, or combination of these methods.

Frequency

The rate of breast cancer varies widely throughout the world. It is less widespread in South Asia and Far East, more common in Europe and even the United States. According to the American Cancer Society, breast cancer is rare among Asians and more prevalent among blacks (high rates may also be influenced by the increased effort detection).

Prostate cancer develops most often in men over fifty years. This is the type of cancer most common in men, where he is responsible for more deaths than any other cancer (except lung cancer). However, many men who develop prostate cancer symptoms do not, do not undergo any therapy and die for other reasons. Many factors of genetic origin, toxicological and diet-related seem involved in the development of this cancer.

We find outbreaks of cancer cells in 30 to 70% of cases in studies performed in autopsies of men 70 to 80 years; prostate cancer remains the most often asymptomatic: the probability of a man 50 years know a diagnosis of prostate cancer is only 10%. In 3% of cases, this cancer will be fatal.

Geography of Prostate Cancer

There are significant differences in the expression of this cancer, which seems more common among the black man, or where the family has a history pathological with this condition. From 1983-2002, while deaths from cancer were generally higher in the Caribbean city, deaths from prostate cancer and stomach were twice as common in the Caribbean in the mainland (while colorectal cancer and lung cancer were three times less frequent). This could be explained by both genetic reasons and food (green tea and / or soybeans or other foods rich in selenium) which appear to protect most Japanese living in Japan (while living in the United States is not).

Causes

They are not known with precision.

There is a genetic predisposition and the presence of certain genes seems slightly correlated with the onset of the disease. In particular, a mutation on chromosome 8 might explain the higher incidence of this cancer in black American.

Nutritional causes were discussed with a potentially protective role of lycopene. Similarly, exercise may have a slightly protective effect and tobacco a deleterious effect.

Symptomatology and detection

In most cases, prostate cancer is asymptomatic, ie it is discovered when it does not own event to it. It is most often found:

During blood tests, including investigation of the PSA (specific antigen for prostate, whose predictive value and use, without proven benefit to public health, has recently been called into question). The PSA is a protein normally secreted by prostate cells, but cancer cells secrete 10 times more than a normal cell. This property has raised many hopes in terms of screening. The blood level of PSA can be increased by many other factors (the prostate volume, infections and / or inflammation, the mechanical (digital rectal other)...) or decreased by certain treatments for benign hypertrophy (ministered). The thresholds of significance are therefore difficult to establish. It is recognized, however, rates of PSA between 4 and 10 ng / ml are doubtful, but it is clearly significant beyond. Some authors have proposed to bring the rate to its actual weight of the prostate, or assess the free PSA / total PSA, or the kinetic growth rate over 2 years. Scorer still uncertain for screening, the PSA level is, however, a key indicator for monitoring and treatment of cancers reported.

During a rectal examination, conducted as systematic or because of symptoms related to another illness (especially benign prostatic hypertrophy) incidentally, on parts of resection of the prostate during surgical treatment of prostate adenoma.

When it is symptomatic prostate cancer is most often at an advanced stage. It can lead to: acute retention of urine, hematuria, sexual impotence, impaired general condition pain and / or malfunction or failure of other organs associated with the presence of metastases

Diagnosis

The diagnostic orientation based on two key elements: the digital rectal examination and determination of PSA blood. The abnormality of one or both leaves suspect prostate cancer. It will be confirmed or not, by taking a sample of the prostate (biopsy) for examination under a microscope. Only the positivity of these biopsies permits to plan and begin treatment of this cancer. Once confirmed the diagnosis of prostate cancer, we conduct a bone scan in search of bone metastases and abdomino-pelvic CT or MRI abdomino-pelvic to clarify the extension of the tumor in the prostate and houses of possible pelvic lymph node metastases, retroperitoneal or liver.

Clinique

Clinical examination is the fundamental digital rectal exam.

The most specific induration of the gland. This induration may be nodular, it may also involve an entire lobe or the entire gland palpable. A heterogeneous consistency or asymmetry are much less specific signs, which can also translate a simple adenoma, particularly when the prostate is larger.

Ultrasound trans-rectal biopsies

There is currently no consideration imaging practice that could only detect an outbreak of prostate adenocarcinoma with a sensitivity and specificity satisfactory.

Contrary to popular belief still widespread, and although this review and is still often prescribed endorectal ultrasound alone has no relevance to the positive diagnosis of prostate cancer, under the inconvenience it is likely to cause. It shall, however, when its interest is used to guide prostate biopsies. Other imaging modalities (scan, MRI) have an interest in the balance sheet expansion.

Technique

An endorectal ultrasound probe equipped with a guide needle is inserted into the rectum. Biopsies were performed with needles fitted with a notched mandrel. The mandrel penetrates the first. The needle just cover, and decide to imprison and the fragment of prostate located in the notch. The movement of chuck and the needle are automated by a system of springs and the taking is a few hundredths of a second. The screen of the ultrasound, with a landmark representing the path of the needle, permits, thus firing biopsy very precise.

The number of biopsies, and where they should be, are not well codified and many protocols have been proposed: the aim is to obtain a sample as representative as possible. Currently, it is frequently performed 5 to 6 samples per lobe, or 10 to 12 in total. These numbers may be reduced or increased depending on the size of the prostate, tolerance of the patient, or if a second set of biopsies.

Preparation and conduct

This is a frequently performed as an outpatient, ie without hospitalization, or during hospitalization "for days". A rectal preparation (enemas) is often advocated. Many centers now offer systematic antibiotic (short antibiotic treatment to reduce infectious complications). The concomitant anticoagulation is in principle against inappropriate and that any treatment can be subject to arrest or a temporary modification.

Tolerance

Acceptance of the review is particularly variable from one patient to another. Each biopsy is shooting itself very painful. However, their repetition, and especially the presence and movement of the probe are the main factors of discomfort. The inconvenience of this review may justify the use of local or general anesthesia. Local anesthesia with a gel anesthetic (lidocaine gel) has never demonstrated its effectiveness. Local anesthesia by injection of lidocaine on each side of the prostate (nerves pudendaux) has shown in many studies improved tolerance of the examination, however incomplete, because of its low efficiency discomfort associated with the presence of the probe. Anesthesia "general" Mild equimolar mixture of oxygen and nitrous oxide ( "MEOPA") has recently been evaluated and appears very effective in this indication. It is even more interesting that easy to implement because does not require an anesthetist and seems almost devoid of side effects. General anesthesia "classic" is rarely used, reserved for patients who have suffered greatly during the first of a series of prostate biopsies.

Suites

Any pain disappear in a few tens of minutes. Can occur fairly frequent small bleeding through the anus and in urine for 24 to 72 hours without gravity. Small nets blood may also interfere with sperm for several days, again without any consequences.

Anatomopathologie

Cancer begins peripheral portion of the gland, unlike benign prostatic hypertrophy of interest to the central area, périurétrale.

The diagnosis is focused on the examination of the biopsy or surgical specimen.

The seriousness of evolution is correlated with the microscopic appearance (Gleason score), the level of PSA and the spread of the disease.

Bilan extension

The spread of the disease when the disease must be determined in order to better tailor therapy. Therefore the presence of bone metastases, lung and liver, knowing that bone metastases are most frequent. We must look for lymph node metastases in the pelvis and the retrograde (around the abdominal aorta). it must finally try to clarify the extension of the tumor in the prostate, particularly whether the latter exceeds the prostate capsule or not.

The means of imaging used in routine generally low ability to show (ultrasound scan, MRI) or to precisely locate (scan) the original prostate lesions, owing to the low blood of breast cancer. MRI is the least bad review to determine the local extension.

MRI scanners or new generation (volume) are used to search the achievement of lymph nodes, but only nodes whose size is increased are detected. New products in contrast MRI, so-called "super-para-magnetic" could improve the detection of lymph nodes affected.

The positron emission tomography (PET camera, PET-scan) did not indicate however, because of very little or no hypermetabolism prostate cancer.

a blood test can check the status of kidney and liver functions.

Treatment

The age, overall health of humans as well as the extent of spread, appearance under the microscope and the response of cancer to initial treatment are important to predict the outcome of the disease.

As prostate cancer is a disease of elderly men, many will die for other reasons before the prostate cancer could spread or cause symptoms. This makes the difficult choice of treatment. Decide whether or not we treat localized cancer of the prostate (a tumor confined within the prostate) with intent to heal is that arbitration must be made between the positive and negative expected to point of view of patient survival and quality of life.

The treatment should be discussed on a case by case basis following the extension of cancer, the patient's general condition and related diseases. A simple monitoring may be recommended in the elderly or among holders of a very localized.

Medical treatment

Hormone

There is a correlation between the production of testosterone (male hormone) and the multiplication of cancer cells. A blocking or greatly reducing the production of this hormone can effectively curb the disease. Some drugs are administered as a subcutaneous injection every 3 months. Others are administered orally. Side effects are, however numerous, but rarely serious. The hormone, which was the treatment of advanced forms, or metastatic, saw its indications extended to the treatment of tumors rejected for surgery (because of the size of the tumor, the risk of surgery not complete ,...) and why the rate of relapse after radiotherapy remained important. The overall control of the disease, adding radiotherapy and hormone therapy for 3 years, can improve significantly the number of patients for whom the disease remains undetectable. The pulpectomy (testicular tissue ablation) is no longer used since the 90s.

Chemotherapy

Until the early 2000s, the use of cytotoxic chemotherapy in metastatic prostate cancer, and whose usual treatment hormonotherapy by becoming ineffective (tried in particular on increasing PSA despite repeated androgen suppression) 's has proved a failure. The advent of docetaxel (Taxotere °) amended the therapeutic possibilities, Entr'ouvert by mitoxantrone (Novantrone °) some years earlier. For the first time, a drug used in advanced stages of the disease, managed to improve survival and quality of life of patients. Three controlled studies confirm these results. Others are underway to integrate chemotherapy early in the history of the disease for locally advanced tumors, where organic growth but before the onset of metastases, and why not, immediately after surgery to treat possible micro-metastases.

Surgery

It is based on the prostatectomy, known as radical or total. It involves the removal of the prostate and seminal vesicles and may be preceded by a levy of lymph drainage of the prostate. The surgery can be done through open (surgical incision in the abdomen or at the perineum) or by abdominal Coelioscopy; surgery is reserved for cancer localized to the prostate and offers great chance of cure if the cancer is actually located and slightly or moderately aggressive (aggressiveness estimated by the Gleason score), and may lead to urinary incontinence, most often temporary and erectile dysfunction. Currently, there is no superiority of one technique over another with regard to cancer outcomes and results urinary and sexual function.

Coelioscopy

Coelioscopy prostatectomy was used by an American team which published it abandoned in 1997 after 8 cases as the intervention was difficult. It is the French teams that end 1997 and early 1998 took the torch and showed that this technique was feasible. Gaston de Bordeaux, and VALLANCIEN Guillonneau Paris and developed the technical standardization. VALLANCIEN and his team published the technique by transpéritonéale then through peritoneal under which seems simpler. It is now recognized worldwide. With an experience of almost 3,000 transactions, the surgical team Montsouris Institute in Paris has shown the benefits of prostatectomy Coelioscopy: we must retain the shorter hospital stay (5 days against 8 in average according to statistics PMSI 2004, the post operative pain near zero even lower, the rate of transfusion of about 2 to 3% against an average of 15% for open surgery. The strictures of the suture between the bladder and urethra canal are more rare (1.5%). The resumption of activity is fast after about a week.

Cryoablation

The prostate cancer tissue may be destroyed by local application of a very cold gas. The cryoprobe (most often cooled with liquid nitrogen) is introduced in endourétral until the prostate, the correct position of cryode can be verified by various techniques including endoscopy conducted by a pubic trocard addition, transvésical. A cycle of freezing and thawing will be implemented for a few minutes and repeated if necessary, a probe is placed urétrovésicale end technology and allow the evacuation progressive tissue nécrosés by applying the cold, some practicing Transurethral resection of tissue mortified by cryotherapy to accelerate the process. Another technique involves placing special needles through perineal ultrasound and under control.

More about Prostate Cancer: http://treatmentnews.blogspot.com.









Sunday, August 8, 2010

Primary peritoneal cancer prognosis - is a death sentence?


A cancer diagnosis is devastating. A stage IV cancer diagnosis is even worse. Primary Peritoneal Cancer Prognosis is not great but it is manageable. This cancer mimics ovarian cancer in that few symptoms show up until it is quite advanced. Standard treatments include surgery and chemotherapy.

There are other forms cancer that seem to hide or be misdiagnosed until they are very advanced. One is GIST-Gastro Intestinal Stroma tumor. Just a few years ago, a diagnosis of this stomach lining tumor was enough to start making funeral arrangements. But that is not the case now. Thanks to advances in research and actually separating this type of tumor from other cancers that were all lumped into the stomach cancer category, a diagnosis of GIST is no more an immediate death sentence.

A couple of drugs on the market have made a big difference. One is called Gleevec and the other is called Sutent. Gleevec is usually the first line of defense. This drug is a protein inhibitor that attacks the tumor and shrinks it. It has a 70% success rate which is unheard of for most kinds of cancer.

Interestingly, it was initially used in the treatment of leukemia and was used by a doctor as a last ditch effort for a patient who was dying of GIST. It is now standard protocol for GIST treatment.

Gleevec is not without its side effects but most are manageable. One of them is short term memory loss. That's not a big deal to you are in line at the post office and can't remember where the package your are mailing is supposed to go.

Primary peritoneal cancer prognosis will also be more favorable as other drugs are developed for treatment of this specific type of Cancer. Research is ongoing and breakthroughs are being made all the time.








Faye Herl writes about Facing Cancer Now at http://www.facingcancernow.com


Saturday, August 7, 2010

Types of cancer, the connection with asbestos


Asbestos is a naturally-occurring fibrous mineral, known to Greeks as "miracle mineral" due to its durability, flexibility, and resistance to heat and chemical damages. Asbestos is composed of long and thin fibers that become airborne when damaged and disturbed. In the United States, the mineral is used in numerous industries and about 3,000 commercial products including: vinyl tiles, caulk, roofing and ceiling tiles, brakes shores, textiles, insulation, cement, and many more. It is used as fireproofing and insulating material in factories, schools, homes, and ships.

What are the Types of Cancer Caused by Asbestos?

Despite the many uses of asbestos, it is now considered as hazardous to public health. Studies have finally found out heavy and prolonged exposure to asbestos causes several serious illnesses to people.

Mesothelioma. This is a rare type of cancer that is almost exclusively caused by asbestos exposure. Even though the incidence rate has decreased in recent years, about 2,000 new cases of mesothelioma are diagnosed every year in the US.

There are three types of mesothelioma. Pleural mesothelioma develops in the lining of the lungs and considered as the most common. Peritoneal and pericardial esothelioma affect the membrane that surrounds the abdominal cavity and the heart, respectively.

The prognosis is poor because condition is often diagnosed in the advanced stages; mainly because symptoms are typically late to appear. There is no cure but different treatment options are available.

Lung Cancer. This disease is not directly linked to asbestos exposure; but the risk gets higher when combined with smoking.

Laryngeal Cancer. There is some evidence that links asbestos as cause of cancer of the larynx (or voice box).

Kidney Cancer. Many studies have shown that asbestos may also cause this type of cancer.

Other cancerous illnesses include: colon, intestinal, esophageal, and gallbladder.

Who is at Risk for Asbestos-Related Cancer?

People who are exposed to asbestos are holding high-risk occupations like: construction and demolition, shipbuilding and shipyard work, drywall removal and installation, auto brake repair, firefighting, and fireproofing.

Asbestos is not harmful when still whole and intact. When disturbed and damaged, it releases microscopic fibers into air. When inhaled or ingested by humans, these fibers get lodged in the tissues and cause inflammation that can lead to malignant tumor.








David Austin is an Attorney focused on complex injury cases. You can learn more about Cancers Associated with Asbestos at his website. http://www.Burke-Eisner.com


Friday, August 6, 2010

What is mesothelioma (asbestos cancer)?


Mesothelioma is a rare type of cancer that is believed to affect around 2000 people in the UK each year. It develops when the cells of the mesothelium (a thin membrane that covers the chest and abdomen) start to multiply in a rapid and uncontrollable way and can take up to 60 years to fully develop. In this article I will be discussing this type of cancer in greater detail.

As I already said asbestos cancer develops in the mesothelium. The mesothelium is actually divided into two parts. The first is the pleura which lines the lungs. The pleura is comprised of an inner layer and an outer layer which slide over each other as you breath. If it develops in this area it is known as pleural mesothelioma and it causes the two layers to become thicker. The second is the peritoneum which lines the abdomen and it also has an inner layer and an outer layer. If it affects this area it is known as peritoneal mesothelioma and it also causes these layers to become thicker.

Both types can be very painful and lead to a number of undesirable symptoms. Pleural mesothelioma can cause breathlessness, coughing and chest pain. It can also lead to pleural effusion where lubricating fluid in the lungs becomes trapped between the inner and outer layers of the pleura. Peritoneal mesothelioma can lead to abdominal pain, bowel problems and it swelling in the abdomen.

Almost every asbestos cancer diagnosis is caused by exposure to that very substance. In the past asbestos was a very popular construction material in the UK. However, as people became more knowledgeable they learnt about the dangers associated with this material. In particular they discovered that the very fine fibres that make up asbestos are easily released when the material is handled. This led to a complete ban on the importing and use of asbestos being imposed in the UK in 1999.

Asbesos cancer is a very rare type of cancer and is believed to affect one person in every million. However, it can be deadly. If you have previously been exposed to asbestos you should go see your doctor right away and explain your concerns. Even if it turns out that you do not have this type of cancer it is better to be safe than sorry.

Whilst every intention has been made to make this article accurate and informative, it is intended for general information only. Mesothelioma is a very serious, life threatening condition and you should discuss any concerns, treatments or lifestyle changes fully with your doctor.








Tom Parker owns and operates a number of useful fitness resources and websites. You can learn more about mesothelioma and how improving your fitness can help you prevent cancer by visiting Free Fitness Tips.